These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16375591)

  • 1. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability.
    Albers S; Mir TS; Haddad M; Läer S
    Clin Chem Lab Med; 2006; 44(1):80-5. PubMed ID: 16375591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP concentrations indicate cardiac disease in pediatric patients.
    Geiger R; Hammerer-Lercher A; Url C; Schweigmann U; Puschendorf B; Sommer R; Stein JI; Mair J
    Int J Cardiol; 2007 Dec; 123(1):63-5. PubMed ID: 17289184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.
    Lin CW; Zeng XL; Zhang JF; Meng XH
    J Card Fail; 2014 Mar; 20(3):168-73. PubMed ID: 24361777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals.
    Soldin SJ; Soldin OP; Boyajian AJ; Taskier MS
    Clin Chim Acta; 2006 Apr; 366(1-2):304-8. PubMed ID: 16360137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of N-terminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients.
    Hammerer-Lercher A; Geiger R; Mair J; Url C; Tulzer G; Lechner E; Puschendorf B; Sommer R
    Clin Chem; 2006 Jul; 52(7):1415-9. PubMed ID: 16690739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of serum N-terminal pro-brain natriuretic peptide levels for prognosis of patients in intensive care unit].
    Liu J; Zhang X; Liu Y; Wang B; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):489-92. PubMed ID: 25027427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood.
    Zugck C; Nelles M; Katus HA; Collinson PO; Gaze DC; Dikkeschei B; Gurr E; Hayen W; Haass M; Hechler C; van Hoof V; Guerti K; van Waes C; Printzen G; Klopprogge K; Schulz I; Zerback R
    Clin Chem Lab Med; 2006; 44(10):1269-77. PubMed ID: 17032141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010.
    Di Serio F; Ruggieri V; Varraso L; De Sario R; Mastrorilli A; Pansini N
    Clin Chem Lab Med; 2005; 43(11):1263-73. PubMed ID: 16232094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-terminal pro-B-type natriuretic peptide value for prediction of mortality among critically ill patients in different age groups in intensive care unit].
    Li H; Wang H; Lou Y; Miao W; Sha N
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):508-12. PubMed ID: 25027431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D; Oral I; Lacnák B; Juráková R; Horalík D; Adamovská S; Prosková J; Hrabovská I; Ozanová G
    Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.